Rubin Steven D, a director, made two open market purchases of Entera Bio Ltd. ($ENTXW) shares in the last 365 days, totaling $19,450, with the most recent on February 12, 2026. These rank 3,878th among 4,983 individual insiders, below the average of 1.5 million dollars per buyer across 3.29 transactions. He also sold Red Violet, Inc. ($RDVT) shares once for $389,300 on March 19, 2025, ranking 7,006th among 11,678 insiders, well under the average of 8.6 million dollars across 6.37 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | Entera Bio Ltd. | $ENTX | Rubin Steven D | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 5000 | $1.49 | 15,000.0000 | 47,089,814 | 50.00% | 0.01% |
| Feb. 9, 2026 | Entera Bio Ltd. | $ENTX | Rubin Steven D | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 10000 | $1.20 | 10,000.0000 | 47,089,814 | 9999.99% | 0.02% |
| Jan. 9, 2026 | Cocrystal Pharma, Inc. | $COCP | Rubin Steven D | Director | A | Stock Options (Right to Buy) | 16410 | $0.00 | 16,410.0000 | 13,784,065 | 9999.99% | 0.12% |
| Dec. 19, 2025 | Red Violet, Inc. | $RDVT | Rubin Steven D | Not found | A | Common Stock | 4450 | $0.00 | 145,588.0000 | 14,618,657 | 3.15% | 0.03% |
| June 24, 2025 | Niagen Bioscience, Inc. | $NAGE | Rubin Steven D | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 78,125,000 | 9999.99% | 0.03% |
| May 27, 2025 | OPKO HEALTH, INC. | $OPK | Rubin Steven D | Executive VP-Administration | A | Stock Option (Right to Buy) | 437500 | $0.00 | 437,500.0000 | 998,363,636 | 9999.99% | 0.04% |
| March 19, 2025 | Red Violet, Inc. | $RDVT | Rubin Steven D | Not found | S | Common Stock | 10000 | $38.93 | 141,138.0000 | 14,125,825 | 6.62% | 0.07% |
| Nov. 4, 2024 | Red Violet, Inc. | $RDVT | Rubin Steven D | Not found | A | Common Stock | 8000 | $0.00 | 151,138.0000 | 14,311,575 | 5.59% | 0.06% |
| Oct. 9, 2024 | Cocrystal Pharma, Inc. | $COCP | Rubin Steven D | Director | A | Common Stock | 18957 | $0.00 | 2,660,242.0000 | 0 | 0.72% | 0.00% |
| July 24, 2024 | OPKO HEALTH, INC. | $OPK | Rubin Steven D | Executive VP-Administration | A | Common Stock | 437500 | $0.00 | 6,625,232.0000 | 0 | 7.07% | 0.00% |
| June 20, 2024 | Niagen Bioscience, Inc. | $NAGE | Rubin Steven D | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 74,985,000 | 9999.99% | 0.03% |
| Jan. 5, 2024 | OPKO HEALTH, INC. | $OPK | Rubin Steven D | Executive VP-Administration | P | Common Stock | 10000 | $0.87 | 6,187,732.0000 | 0 | 0.16% | 0.00% |
| Nov. 30, 2023 | Red Violet, Inc. | $RDVT | Rubin Steven D | Director | A | Common Stock | 10800 | $0.00 | 143,138.0000 | 0 | 8.16% | 0.00% |
| Nov. 10, 2023 | OPKO HEALTH, INC. | $OPK | Rubin Steven D | Executive VP-Administration | P | Common Stock | 10000 | $1.30 | 6,177,732.0000 | 0 | 0.16% | 0.00% |
| July 18, 2023 | Cocrystal Pharma, Inc. | $COCP | Rubin Steven D | Director | A | Stock Options (Right to Buy) | 17233 | $0.00 | 17,233.0000 | 0 | 9999.99% | 0.00% |
| May 18, 2023 | OPKO HEALTH, INC. | $OPK | Rubin Steven D | Executive VP-Administration | A | Stock Option (Right to Buy) | 700000 | $0.00 | 700,000.0000 | 0 | 9999.99% | 0.00% |